Document Detail


Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol >/=125 mg/dl treated with statins.
MedLine Citation:
PMID:  12403804     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: We report the incidence of new coronary events and new atherothrombotic brain infarction (ABI) in older men and women with diabetes mellitus, prior myocardial infarction, and a serum low-density lipoprotein (LDL) cholesterol of >/=125 mg/dl treated with statins and with no lipid-lowering drug. METHODS: The incidence of new coronary events and of new ABI was investigated in an observational prospective study of 529 diabetics, mean age 79 +/- 9 years, with prior myocardial infarction and a serum LDL cholesterol of >/=125 mg/dl treated with statins (279 persons or 53%) and no lipid-lowering drug (250 persons or 47%). Follow-up was 29 +/- 18 months. RESULTS: At follow-up, the stepwise Cox regression model showed that after controlling for other risk factors, the use of statins was associated with a 37% significant independent reduction in the incidence of new coronary events and with a 47% significant independent reduction in the incidence of new ABI. CONCLUSIONS: Use of statins was associated with a 37% significant, independent reduction in new coronary events and a 47% significant, independent reduction in new ABI in older men and women with diabetes mellitus, prior myocardial infarction, and a serum LDL cholesterol of >/=125 mg/dl. Elderly diabetics with prior myocardial infarction and increased serum LDL cholesterol should especially be treated with statins.
Authors:
Wilbert S Aronow; Chul Ahn; Hal Gutstein
Related Documents :
9568444 - Progression of coronary artery disease in young male post-infarction patients is linked...
20173304 - Effect of vessel size on lipid content of coronary plaques assessed by integrated backs...
9395824 - Cholesterol and atherosclerosis: a contemporary perspective.
11834934 - Lipid risk factor correlates of ischemic heart disease as diagnosed by myocardial perfu...
22354194 - First-in-man study of simvastatin-eluting stent in de novo coronary lesions: the simvas...
15757074 - Congenital coronary artery anomalies in the adult: a new practical viewpoint.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journals of gerontology. Series A, Biological sciences and medical sciences     Volume:  57     ISSN:  1079-5006     ISO Abbreviation:  J. Gerontol. A Biol. Sci. Med. Sci.     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2002-10-29     Completed Date:  2002-12-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9502837     Medline TA:  J Gerontol A Biol Sci Med Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  M747-50     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Division, Department of Medicine,Westchester Medical Center/New York Medical College, Valhalla, USA. WSAronow@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Cerebral Infarction / prevention & control*
Cholesterol, LDL / blood*
Diabetes Complications*
Diabetes Mellitus / blood
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / complications,  drug therapy*
Intracranial Arteriosclerosis / prevention & control
Male
Myocardial Infarction / blood,  complications*,  prevention & control*
Prospective Studies
Recurrence / prevention & control
Chemical
Reg. No./Substance:
0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Undernutrition and risk of mortality in elderly patients within 1 year of hospital discharge.
Next Document:  The 6-minute walk test in mobility-limited elders: what is being measured?